Lataa...
Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal–CA1 projection
BACKGROUND: Memantine, a low- to moderate-affinity uncompetitive N-methyl-D-aspartate receptor antagonist, has been shown to improve cognitive functions in animal models of Alzheimer’s disease (AD). Here we treated APP/PS1 AD mice with a therapeutic dose of memantine (20 mg/kg/day) and examined its...
Tallennettuna:
| Julkaisussa: | BMC Neurosci |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8201811/ https://ncbi.nlm.nih.gov/pubmed/34120588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12868-021-00647-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|